Skip to main content

Table 1 Patients' characteristics

From: log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

   All patients Q I Q II Q III Q IV Q V P
n   585 117 117 117 117 117  
log (TG). HDL-C -1   0.053 0.032 0.042 0.050 0.060 0.082 ~
age years 65 (12) 67 (12) 67 (12) 63 (12) 65 (12) 63 (10) 0.0083
smoking * % 36/64 41/59 44/56 40/60 31/69 24/76 0.0010
ethanol U.week-1 16 (23) 21 (25) 19 (21) 16 (24) 14 (21) 11 (25) 0.0093
LT physical activity ** % 60/40 55/45 53/47 58/42 67/33 68/32 0.0072
LT screen watching *** hr.day-1 3.1 (1.8) 2.7 (1.8) 2.8 (1.6) 2.8 (1.6) 3.0 (1.5) 4.0 (2.2) <0.0001
BMI kg.m-2 28.8 (5.1) 26.5 (4.9) 27.9 (4.5) 29.2 (5.0) 30.1 (5.0) 30.4 (5.3) <0.0001
waist circumference cm 105 (13) 98 (13) 103 (11) 105 (12) 109 (12) 109 (13) <0.0001
conicity index m2.kg-1 1.35 (0.08) 1.33 (0.08) 1.35 (0.07) 1.36 (0.08) 1.37 (0.07) 1.37 (0.08) 0.0002
fat mass % 27.4 (6.2) 25.0 (6.7) 26.9 (6.0) 27.5 (6.5) 28.6 (5.5) 28.8 (5.6) <0.0001
visceral fat 0 - 30 14 (5) 12 (5) 13 (4) 14 (5) 15 (4) 15 (5) <0.0001
liver steatosis % 68 50 61 69 72 83 <0.0001
insulinaemia pmol.l-1 113 (77) 80 (47) 103 (67) 122 (98) 125 (83) 132 (71) <0.0001
HOMA S % 53 (34) 69 (39) 61 (40) 50 (30) 49 (30) 39 (23) <0.0001
HOMA product (B × S) % 28.5 (18.2) 35.7 (21.6) 31.1 (16.2) 26.7 (15.8) 26.7 (16.2) 22.5 (16.5) <0.0001
(B × S) loss rate %.yr-1 1.29 (0.45) 1.15 (0.50) 1.18 (0.33) 1.38 (0.52) 1.28 (0.40) 1.44 (0.39) <0.0001
metabolic syndrome % 76 36 67 83 95 97 <0.0001
metabolic syndrome score 1/5 to 5/5 3.4 2.3 2.9 3.5 4.0 4.4 <0.0001
statin/fibrate % 54/21 49/9 51/11 59/21 57/16 56/46 NS/<0.0001
macroangiopathy % 40 29 38 44 40 48 0.006
   CAD % 29 15 32 32 31 33 0.0097
   TIA/stroke % 9 5 5 10 10 13 0.0129
   PAD % 12 15 13 11 8 14 NS
  1. Results are expressed as means (1 SD) or proportions (%). *: never vs. former/current; **: no leisure-time (LT) physical activity (PA) vs. any level of LT-PA. CAD: coronary artery disease; BMI: body mass index; HOMA B & S: beta-cell function and insulin sensitivity from homeostatic model assessment; PAD: peripheral artery disease; Q: quintile; TIA: transient ischaemic attack. NS: not significant.